Kalium Health is leading a patient-focused approach to improve kidney disease management - a significant issue costing US Medicare $2 billion weekly. Kalium Health's first product is a blood potassium self-test, which is crucial for managing a major risk and cost in kidney disease treatment. The team has developed effective blood sensing technology, established a clear regulatory path, and planned a targeted approach to enter the market. Their ultimate goal is to improve the standard of care for millions of patients.









